The New Zealand medical journal · 2026
Aotearoa New Zealand public strongly support investment in cancer treatment and care services: findings from a national survey.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Signal Virginia, Iosua Ella, Gregory Kate, Neumann Rachael, Stairmand Jeannine L, Bateman Jerram, Gray Andrew R, Peniamina Rana L, Signal Louise, McNoe Bronwen M
Аннотация
AIM: Cancer remains a leading cause of morbidity and mortality in Aotearoa New Zealand, with rising incidence, persistent inequities and pressure on diagnosis, treatment and workforce capacity. This study examined public views on government funding, access and delivery of cancer diagnosis, treatment and supportive care services, perceptions of health workforce support and willingness to pay additional tax for healthcare funding.
METHODS: We analysed data from a nationally representative cross-sectional online survey of adults aged 18 years or older conducted between November and December 2025. Participants were recruited using quota sampling, with oversampling of Māori and Pacific people. Weighted analyses assessed support for eight cancer funding proposals, perceptions of health workforce support and willingness to pay additional tax.
RESULTS: We received 1,635 responses, with Māori (n=385; 23.5%, unweighted) and Pacific people (n=368; 22.5%, unweighted) oversampled. All eight proposals received very high support (weighted estimates were 91.4-94.4%), strongest among those aged ≥50 years, and substantial cross-party support by voting intention. Fewer than one-third (29.4%) thought the government was doing enough to support the health workforce. Most (62.3%) were willing to pay additional tax for healthcare funding.
CONCLUSION: There is strong, cross-party support for increased investment in cancer services, alongside concern about health workforce sustainability. Furthermore, there is a willingness to pay additional tax for healthcare funding.
METHODS: We analysed data from a nationally representative cross-sectional online survey of adults aged 18 years or older conducted between November and December 2025. Participants were recruited using quota sampling, with oversampling of Māori and Pacific people. Weighted analyses assessed support for eight cancer funding proposals, perceptions of health workforce support and willingness to pay additional tax.
RESULTS: We received 1,635 responses, with Māori (n=385; 23.5%, unweighted) and Pacific people (n=368; 22.5%, unweighted) oversampled. All eight proposals received very high support (weighted estimates were 91.4-94.4%), strongest among those aged ≥50 years, and substantial cross-party support by voting intention. Fewer than one-third (29.4%) thought the government was doing enough to support the health workforce. Most (62.3%) were willing to pay additional tax for healthcare funding.
CONCLUSION: There is strong, cross-party support for increased investment in cancer services, alongside concern about health workforce sustainability. Furthermore, there is a willingness to pay additional tax for healthcare funding.